ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
143 hedge funds and large institutions have $1.75B invested in Alder Biopharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 36 increasing their positions, 38 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 38
95% less call options, than puts
Call options by funds: $5.68M | Put options by funds: $115M
Holders
143
Holding in Top 10
8
Calls
$5.68M
Puts
$115M
Top Buyers
| 1 | +$78.6M | |
| 2 | +$67M | |
| 3 | +$62.5M | |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$58.2M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$58.1M |
Top Sellers
| 1 | -$133M | |
| 2 | -$121M | |
| 3 | -$51.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$46.2M |
| 5 |
Goldman Sachs
New York
|
-$37.5M |